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Abstract
Background: The structural maintenance of chromosome proteins SMC1 and SMC3 play an
important role in the maintenance of chromosomal integrity by preventing the premature
separation of the sister chromatids at the onset of anaphase. The two proteins are constitutive
components of the multimeric complex cohesin and form dimers by interacting at their central
globular regions.
Results: In order to identify proteins that by binding to SMC3 may interfere with the protein
dimerization process, a human cDNA library was screened by the yeast two-hybrid system by using
the hinge region of SMC3 as bait. This has lead to the identification of Hinderin, a novel five domains
protein including two coiled-coil motifs and sharing a strikingly structural similarity to the SMC
family of proteins. Hinderin is ubiquitously expressed in human tissues. Orthologue forms of the
protein are present in other vertebrates but not in lower organisms. A mapping of the interaction
sites revealed that the N- and C-terminal globular domains mediate the binding of Hinderin to
SMC3. Hinderin/SMC3 complexes could be recovered by immunoprecipitation from cell lysates
using an anti-SMC3 antibody, thus demonstrating that the two proteins interact in vivo. On the
contrary, Hinderin did not interact with SMC1. In vivo the rate of SMC1/SMC3 interaction was
decreased by the ectopic expression of Hinderin.
Conclusions: Hinderin is a novel binding partner of SMC3. Based on its ability to modulate SMC1/
SMC3 interaction we postulate that Hinderin affects the availability of SMC3 to engage in the
formation of multimeric protein complexes.

Background
The structural maintenance of chromosome (SMC) proteins are involved in several aspects of chromosomal
dynamic, in DNA recombination and in DNA repairs [13]. Two SMC proteins named SMC1 and SMC3 bind to
and prevent the premature separation of sister chromatids
at the end of mitosis [4,5]. SMC1 and SMC3 directly interact through their central globular binding domains by

forming an heterodimer [6,7]. The protein complex encircles the sister chromatids and is stabilized though the
interaction with two other cohesin proteins known as
Scc1 and Scc3 in s. cereviasie [7,8]. At anaphase, the ringshaped complex is broken down when separase, a cysteine
protease, cleaves Scc1, thus freeing the sister chromatids
to move in opposite directions [6,9]. Somatic cells with
deranged separase activity or lacking Scc1 develop
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aneuploidy at increased rate. This suggests that the
cohesin complex plays a major role in the maintenance of
chromosomal stability [10-13]. The mechanism regulating the interaction between SMC1 and SMC3 is still
poorly understood. It has however been established that a
single point mutation of the central globular domain
(known as hinge) of either one of these proteins strongly
affects the dimerization rate and prevents the attachment
of the cohesin complex to chromatid DNA [7]. Conceivably, proteins that interact with the hinge domain of SMC1
or SMC3 can act as modulator of the cohesin complex formation and may thus affect chromosomal stability. In this
paper we report the identification of a new SMC3-interacting protein that specifically binds to SMC3's central globular domain. The sequence of the identified gene product
matched that of a previously discovered hypothetical new
protein with no known function. We have named the protein Hinderin. The gene is expressed in all the human tissues analyzed thus far. Orthologue forms of this protein
are expressed in vertebrates but not in lower organisms.
Hinderin is a five-domain proteins and its structure
resembles that of SMC proteins with N- and C-terminal
globular domains that are joined by a coiled coil region
interrupted at the center by a third globular domain.
However, unlike the canonical SMC proteins, Hinderin
does not harbor ABC-like ATPase sequences. We have
found that the protein interacts with the hinge region of
SMC3 but not with SMC1. Hinderin acts as a binding
competitor of SMC1 and, as such, qualifies as a putative
modulator of the SMC3 function.

Results
Identification of Hinderin, an SMC3-interacting protein
with five domain structure including coiled-coil motifs
The region of SMC3 encompassing the protein hinge
domain (Gln465 to Gln807) was used as bait in a yeast twohybrid system to identify interacting proteins expressed by
a human fetal brain Matchmaker two-hybrid cDNA
library (Clontech). About 3 × 106 library clones were
screened. Forty blue colonies reaching 2 mm in size after
one week were collected and 21 of the isolated plasmids
with inserts greater than 500 bp were sequenced. Three of
the sequences matched the same region of the published
cDNA Genbank clones AB037749 (coding for the hypothetical protein KIAA1328) and AL832625 (corresponding to the hypothetical protein DKFZp451C1618). The
inserts of ~2 kb included part of the gene 3'-UTR. However
the 5'-end of the coding region was not present in the
retrieved clones. The issue was complicated by the fact
that the sequences of AB037749 and AL832625 diverged
at their 5'-end. 5'-RACE was thus employed to identify the
transcriptional start site of the interacting gene by using
mRNA derived from fetal kidney 293, hepatoma HepG2,
and cervical HeLa human cells. All the cloned sequence
coincided with that of the AL832625 clone and matched

http://www.biomedcentral.com/1471-2121/6/3

in full the putative coding sequence obtained by automated computational analysis of the human genome
(Genbank XM029429). The conceptually translated
sequence coded for a protein of 578 amino acids.
The exam of the secondary structure of the protein
revealed a remarkable similarity with the structural organization of SMC proteins, particular with regard to the fivedomain structure typical of the SMC protein family. The
protein features C- and N-terminal globular domains,
joined by a coiled-coil sequence interrupted in the middle
by a third globular domain. The size of the central globular domain is similar to that of SMC3 and SMC1 but the
remaining domains are smaller in size. Based on its ability
to interact with the hinge domain of SMC3 and thus to
potentially affect SMC3/SMC1 dimerization, the new protein was named Hinderin. The Hinderin gene spans ~400
kb of the human genome and is located on chromosome
18p11-2. The coding sequence is organized in 10 exons
(fig. 1A). Exon 10 is the largest and contains an extended
3'-UTR. Northern blot hybridization analysis performed
on mRNA from HeLa and colon carcinoma HCT116
human cell lines, showed a single major transcriptional
product of ~4.5 kb (fig. 1B). A correlation between the
exonic organization and the protein structural motifs was
apparent (fig. 1C). The N-terminal globular domain is
encoded by exons 1–3. The first coiled-coil domain is
encoded by exons 4–6. Exon 7 harbors the entire central
globular domain, the central coiled-coil region, and part
of the C-terminal globular domain. The polypeptide
encompassing exons 3 to 6 displays a 36% sequence
homology to the consensus sequence of SMC family of
proteins. A bipartite nuclear localization signal
(R441KERK) is located in exon 7 within a coiled-coil
region. The Hinderin expression pattern in a panel of 16
human tissues was analyzed by semiquantitative RT-PCR
(fig. 1D). The results indicate that the gene is expressed
ubiquitously with the highest expression level detected in
the lung, liver, placenta, kidney, and pancreas. The lowest
expression level was detected in leukocytes and the
prostate.
Mapping of the Hinderin and SMC3 interaction domains
In order to map the region of Hinderin interacting with
SMC3, AH109 yeast was cotransformed with the SMC3465/807 bait and with different Hinderin constructs (fig.
2). Yeast cotransformants of SMC3-465/807 and the Hinderin plasmid retrieved from the two-hybrid library (H47/578) grew rapidly. This result was confirmed by
switching the bait and prey vectors. However, the H-47/
578 construct did not interact with the N- and C-terminal
domains of SMC3 (SMC3-1/186 and SMC3-976/1217
respectively) or with the hinge region of SMC1 (SMC1485/670). A Hinderin construct harboring only the protein central globular domain (H-177/360) furthermore
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Figure 1 Genomic organization, structural domains, and expression pattern in human tissues
Hinderin:
Hinderin: Genomic organization, structural domains, and expression pattern in human tissues. A) The sequence
of the Hinderin ORF was used to BLAST the human genome database. The numeration of the exon boundaries is relative to the
transcriptional start site. The size of the intronic sequences is based on the numeration of the human contiguous sequences. B)
Northern blot hybridization of Hinderin in HeLa and HCT116 cells. A single main transcript of ~ 4.5 kb is identifiable. C) Prediction of coiled-coil domains in Hinderin. The numbers on the abscissa corresponds to the amino acid residues. The probability of the polypeptide to assume a coiled coil conformation is plotted on the ordinate axis. The contribution of the different
exons to the five-domain structural organization of Hinderin is also illustrated. The sequence encoded by exons 3 through 6,
bears a 36% homology to the SMC protein consensus sequence. A bipartite nuclear localization signal is harbored in exon 7. D)
Expression of Hinderin in different human tissues. PCR amplification was stopped after 30 cycles and the product analyzed on
2% agarose staining with ethidium bromide. The G3PDH transcript was amplified in 20 cycles and used to show uniformity of
the source cDNA in the different specimens.

did not interact with the SMC3 bait, thus pointing to a
substantial difference in the binding properties of the
hinge domain of the SMC proteins and the corresponding
domain of Hinderin. On the contrary, both the N- and Cterminal domains of Hinderin (H-1/85 and H-360/578)
interacted with the SMC3 hinge domain. The assay of the
β-galactosidase activity expressed by the yeast as a result of
the protein-protein interaction provided a quantitative
measure of the rate of the process. The strongest interaction was detected between SMC3-465/807 or SMC3-465/
716 and H-47/578. The Hinderin constructs H-1/85 and
H-360/578 displayed a lower interaction activity suggesting that the protein N- and C-terminal domains synergically bind to SMC3. An Hinderin construct (H-64/360),
consisting of the central globular domain in addition to

part of the protein N-terminal domain, displayed binding
activity similar to that of the N-terminal globular domain
alone (H-1/85). The protein central globular domain
therefore does not affect the binding rate of Hinderin to
SMC3. Truncation mutants of SMC3-465/807 were generated to map the region of SMC3 responsible for the interaction with Hinderin. When tested only SMC3-465/716
gave origin to colonies growing at the same rate as
observed with the SMC3 bait (fig. 2). The remaining constructs, in which the SMC3 hinge region had been partially or completely deleted, produced no colonies. The
intact SMC3 hinge domain is thus required for the interaction with Hinderin. Similarly the interaction between
SMC3-465/807 and the hinge region of SMC1 (SMC1485/670) gave strong reactivity whereas truncation
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Figure
Yeast two-hybrid
2
assay of the interaction of different regions of SMC3 and SMC1 with Hinderin
Yeast two-hybrid assay of the interaction of different regions of SMC3 and SMC1 with Hinderin. A) SMC3 and
Hinderin constructs in pGBKT7 are schematized on the left-hand side. All numerals refer to the amino acid sequence. The
SMC3-465/807 construct harbors the protein hinge domain and was utilized as bait for the screening of the Clontech Matchmaker human cDNA library. SMC1, SMC3 and Hinderin constructs cloned in pACT2 or pGADT7 are illustrated on the righthand side of the panel. H-47/577 represents the pACT2 clone retrieved from the screening. We scored the strength of interaction based on the rate of appearance of Blue colonies and the intensity of the color developed. The null score (-) was
assigned when no blue colonies were visible after ten days. To obtain a quantitative measure of the rate of protein interaction,
yeast colonies were grown in selective media and after lysis the β-galactosidase activity released in the supernatant assayed
using a chromogenic substrate as detailed in the Methods. The results shown are the mean ± SD of three independent
determinations.

mutants of SMC3 lacking part of the cohesin protein central globular domain (SMC3-552/807 and SMC3-465/
643) did not interact. This finding is consistent with pre-

vious reports showing that SMC3 and SMC1 dimerization
occurs through interaction of the terminal regions of the
hinge domains of the two proteins [7,14].
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Hinderin interacts with SMC3 in vivo and is a binding
competitor for SMC1
In order to investigate whether Hinderin associates with
SMC3 in vivo, 293 cells were transiently transfected with
1 µg/ml of Hinderin-V5 expression vector and incubated
48 h. The transfected cells displayed three-fold elevation
of the Hinderin transcript level but SMC1 and SMC3
expression was not affected (fig. 3A, V5-IP input lanes and
fig 3B, RT-PCR results). After addition of anti-SMC3 or
alternatively anti-SMC1 antibody to the cell lysate, the
immunocomplexes were analyzed on SDS-PAGE followed by Western-immunoblotting using anti-V5 antibody (fig. 3A). This revealed the presence of Hinderin-V5
in the SMC3 immunoprecipitate. On the contrary, Hinderin-V5 was not detected in the SMC1 immunoprecipitate, thus corroborating the results of the yeast two-hybrid
system interaction experiments. Furthermore, SMC3 but
not SMC1 could be recovered in Hinderin-V5 immunocomplexes. In order to examine whether the interaction
between SMC1 and SMC3 is affected by Hinderin concentration in vivo, experiments were conducted in 293 cells
expressing increasing levels of Hinderin and by assessing
the rate of SMC1-SMC3 interaction using a mammalian
two-hybrid system (Promega Checkmate). In this assay
the interaction between the GAL4:SMC3 activating
domain fusion protein and the VP16:SMC1-binding
domain fusion protein activates the expression of the firefly luciferase encoded by a reporter vector (pGL5). The rate
of interaction between SMC3 and SMC1 is thus directly
proportional to the level of luciferase that is expressed. We
found that transfection of 293 cells with increasing
amount of the Hinderin-V5 expression vector caused a
dose-dependent decrease of luciferase activity. In cells
overexpressing Hinderin, the interaction between the
cohesin proteins was gradually reduced down to ~34% (n
= 3, p < 0.05) (fig. 3B). Ectopic expression of Hinderin
had no effect on the expression of the bait and prey fusion
proteins as determined by RT-PCR, using primers encompassing the coding sequence of fusion proteins. The
results are consistent with the notion that Hinderin competes with SMC1 for binding to SMC3, thereby negatively
affecting the interaction between the two cohesin
proteins.

Discussion
In eukaryotic cells, the disjunction of the sister chromatids
at the onset of anaphase is required to maintain chromosomal stability and to prevent aneuploidy [12,15].
Human somatic cells with unrestrained separase activity
display retarded sister separation and increased rate of
chromosomal breakage [10]. On the other hand, the overexpression of Scc1 in mouse fibroblasts inhibits the cells
proliferation, implicating this protein and its complex
with the other cohesin components in the control of
mitotic cell cycle progression [16]. We have previously
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reported that overexpression of SMC3 has cell transforming potential [17] and we have determined that SMC3
level is controlled in intestinal epithelial cells through the
APC/β-catenin/TCF4 transactivation pathway [18], a signaling system that is almost invariably altered in colon carcinomas. These findings support the idea that alteration of
the level of the components of the cohesin complex has
important consequences that may trigger a tumorigenic
cascade. A key event in the formation of the cohesin multimeric complex is the dimerization of SMC1 with SMC3
which occurs through the interaction between the two
proteins central globular domains. The hindrance of this
process is likely to have a significant effect on the formation and the function of the cohesin complex and on the
maintenance of a stable chromosome population. Given
this postulate, we have screened a human cDNA library to
identify proteins interacting with the hinge region of
SMC3. Clones coding for Hinderin accounted for 15% of
those identified in this screening. Interaction between
Hinderin and SMC3 has been further confirmed by mapping the site of binding, in co-immunoprecipitation
experiments using cell lysates, and in a two-hybrid mammalian system. Furthermore we have determined that
SMC1 and SMC3 interaction rate is inversely related to the
level of Hinderin expressed by mammalian cells. Hinderin displays the same five-domain structural organization of the SMC family [19]. However, the central globular
domain of the protein does not appear to be involved in
the binding with SMC3. Protein-protein interaction studies with a set of truncation constructs are rather consistent
with the conclusion that SMC3 specifically interacts with
the Hinderin terminal globular domains. An interaction
model that is plausible with the protein-protein interaction results is illustrated in fig 4. The model predicts the
occupancy of the hinge region of SMC3 by the two terminal globular domains of Hinderin that come in close
proximity by virtue of the flexibility of the protein central
globular domain. In SMC1 and SMC3 the coiled-coil
domains are in antiparallel orientation and by interacting
they allow the N- and C-globular domains to join and
form a functional ATPase head that interacts with Scc1
[19]. Given the similarity with the structural organization
of the SMC proteins and the interaction modality with
SMC3, the Hinderin coiled coil domains might contribute
to the binding of the N- and C-terminal globular domains
to SMC3.

Conclusions
In summary, we have identified a novel interacting partner of SMC3. The protein, named Hinderin, specifically
interacts with the hinge domain of SMC3. The protein is
ubiquitously expressed in human tissues. We speculate
that when in a certain context, SMC3 association with
Hinderin becomes favored compared to the association to
SMC1, the availability of SMC3 to engage in the cohesin
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3
and competitive binding of Hinderin to SMC3
Protein coimmunoprecipitation and competitive binding of Hinderin to SMC3. A) To monitor the Hinderin interaction, 293 cells were transfected with 1 µg/ml of Hinderin-V5 expression vector and incubated for 48 h. Mock transfected
cells served as control. For SMC1 and SMC3 coimmunoprecipitation experiments, cell lysates (500 µl) were incubated with
either 25 µg of anti-SMC1 or anti-SMC3 antibody for 2 h at RT. The immunocomplexes were then captured on agarose-protein G and analyzed by electrophoresis on 12% SDS-PAGE. After transblotting to a nitrocellulose membrane, Hinderin-V5 was
identified using an anti-V5 monoclonal antibody and HRP-conjugated secondary antibody. The migration position of the Hinderin-V5 fusion protein present in the input cell lysate (200 µl) and in the immunoprecipitate is indicated by an arrow. Goat
immunoglobulins are identified by an asterix. The presence of SMC1 and SMC3 in the Hinderin-V5 immunoprecipitate was
assessed by incubation of cell lysates (500 µl) with 10 µg murine anti-V5 antibody. The immunocomplexes absorbed on agarose-protein G were analyzed on 8% SDS-PAGE and immunoblotted with either anti-SMC1 or anti-SMC3 antibody. SMC1 and
SMC3 immunoblots of the input material (200 µl) are also illustrated. B) The effect of Hinderin on the interaction between the
SMC3 and SMC1 hinge domains was investigated in 293 cells expressing different level of Hinderin by using a mammalian twohybrid assay system. SMC3-474/702 and the SMC1-474/663 hinge domains in pBIND and pACT vectors respectively, were
cotransfected in 293 cells together with Hinderin-V5 expression vector (0.3 or 1 µg/ml) or alternatively 1 µg/ml of the empty
pcDNA3.1 vector (mock-transfected) and the reporter pG5/luc vector using Lipofectamine. Cells transfected with pBIND-Id
and pACT-MyoD fusion protein expression vectors were used as control to assess the specificity of the Hinderin effect on
protein-protein interaction. Luciferase activity was assayed after 48 h. The bars represent the mean ± SD of the values (n = 3).
Semiquantitative RT-PCR was employed to assess the transcript level of GAL4:SMC3 and VP16:SMC1 fusion proteins and of
G3PDH in cells ectopically expressing different levels of Hinderin.
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Figure 4 model of interaction of Hinderin with SMC3
Proposed
Proposed model of interaction of Hinderin with SMC3. A) The five-domain structure of Hinderin is compared to that
of SMC3. The different structural domains are drawn in scale to allow a direct comparison of the size of the terminal globular
regions, the two coiled-coil domains and the central globular domain in the two proteins. B) Mode of interaction of the SMC1SMC3 dimer. The juxtaposition of the cohesins hinge domains interacting through sites located at the globular-coiled coil
domain boundaries (ref. 6) is illustrated. C) Postulated mechanism for the competitive binding of Hinderin to the hinge domain
of SMC3. The N- and C-terminal globular domains of Hinderin are shown to interact with binding sites located on the SMC3
hinge. The Hinderin central globular domain is not involved in the binding to SMC3 but may play a role by orienting the N- and
C-terminal globular domains toward their targets.

complex formation is reduced. The binding of SMC3 to
proteins affecting its association to functional partners
represents a new modality of regulation of SMC3 activity.

Methods
Screening of a human cDNA library by yeast two-hybrid
system
In order to identify proteins encoded by the human fetal
brain cDNA library and interacting with the hinge domain

of SMC3, a bait plasmid was generated by subcloning the
SMC3-465/807 polypeptide coding region into the yeast
two-hybrid system bait vector pGBKT7 (Clontech) (see
fig. 2 for a diagram of the constructs used and their designation). The insert was generated by PCR using Pfu DNA
polymerase and primers terminated with restriction sites
that allowed the directional cloning of the products into
the accepting vector (see Additional file 1 for a listing of
the primers used in this study). Mouse full-lenght SMC3
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cDNA was used as template. To identify the gene encoded
by the interacting plasmid, the prey insert was sequenced
by priming at the Gal4AD site (5'-AATACCACTACAATGGA-3'). The sequences were BLASTed against the nr and
human dEST databases. DNA restriction digestions provided information on the size of the clones retrieved.
5' RACE and cloning of the complete Hinderin coding
sequence
The total RNA was isolated using TRI-reagent from 293,
HepG2 and HeLa cells. The 5' RACE assay was performed
using a RLM-RACE Ambion kit. The generated cDNA was
used as template for nested PCR. The inner PCR product
was cloned into pCRII-Topo vector (Invitrogen) and
sequenced using a T7 primer. The sequence matched that
of the DKFZp451C1618 clone (AL832625) and extended
5' to the published sequence of KIAA1328 (AB037749).
Based on this information, the complete Hinderin coding
region was generated by RT-PCR utilizing mRNA extracted
from 293 cells, and the product cloned in frame with the
tag sequence in pcDNA3.1/V5-His TOPO (Invitrogen).
When transfected into 293 cells, the expressed product
detected with an anti-V5 monoclonal antibody had size
69 KDa, as expected for a protein encoded by the Hinderin-V5 fusion gene (fig. 3A).
Mapping of the protein interacting sites
In order to map the SMC3 interacting site(s) a series of
truncated constructs were produced in pGBKT7 vector.
The inserts required for the SMC3-1/186, SMC3-976/
1217, SMC3-552/807 and SMC3-711/807 constructs
were produced by PCR. SMC3-465/550 and SMC3-465/
716 were generated by introducing stop codons in the
sequence of SMC3-465/807 using a QuikChange XL kit
(Stratagene). The mutated duplex oligonucleotides used
had the forward sequence: 5'-CTTTCTATACTTGTGT
AAGTCACTGCTGGTAAC-3' and 5'-GACCAGTTGATGAACTAAATGCAGATAGAG-3', respectively. SMC3-465/
643 and SMC3-643/807 were obtained by digesting
SMC3-465/807 at the PstI or alternatively the NdeI restriction sites present in the vector multiple cloning site and at
the SmaI site of the insert. The resulting linear constructs
were blunt-ended and religated. pGADT7-SMC3-465/807
was generated by retriving the insert from the bait vector.
SMC1-485/670 encoding the entire SMC1 hinge region,
was generated by RT-PCR from 293 cells mRNA and
cloned in pGADT7. Hinderin deletion constructs H-64/
360 and H-360/578 were generated by restriction digestion of the pACT2-Hinderin-47/578 clone identified in
the yeast two-hybrid system screening with NcoI/BglII and
BglII/XhoI respectively, followed by religation of the
blunt-ended vector. Hinderin in bait pGBKT7 vector was
generated by retrieving the H-47/578 insert from the prey
clone. H-177/360 and H-1/85 inserts were obtained
respectively by PCR and by digestion of the Hinderin
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pcDNA3.1 expression vector with BamHI/EcoRI. Both
were subsequently subcloned in pGADT7. To assess the
strenght of interaction between different SMC3 and Hinderin domains, three colonies were randomly selected
and grown overnight in 5 ml of selection media. After cell
lysis by freeze thawing in 300 ml of 100 mM Na2HPO4 pH
7.0, 10 mM KCl, 1 mM MgSO4, buffer, β-galactosidase
activity was assessed using ortho-nitrophenyl-β-D-galactopyranoside as substrate (1 mM) in the presence of 50
mM β-mercaptoethanol. After 2 h incubation at 37°C the
color intensity was read at 420 nm.
Northern blot hybridization and semiquantitative PCR
Total mRNA was extracted with TRI-reagent from subconfluent HeLa and HCT116 cells and separated on 1% agarose. After transfection to a nitrocellulose filter, the
Hinderin transcript was identified by hybridization to a
335 bp 32P-labeled cDNA probe annealing to the 5'-end
region of the gene. In order to examine the expression of
Hinderin in different human tissues, semiquantitative RTPCR was performed by using 0.5 µg of Marathon-ready
first strand cDNA (Clontech) from 16 tissues. The PCR
reaction was monitored at 20 and 30 cycles and the product analyzed on 2% agarose. In order to normalize for
possible differences in mRNA content, the expression of
the housekeeping gene G3PDH was analyzed in each
sample.
Protein secondary structure prediction and identification
of orthologue forms of Hinderin in other species
The human polypeptide sequence was analyzed with the
COILS program to predict globular and coiled-coil
domains. The scanning window was set at 21. The homology with other known protein family was examined by
querying the NCBI Conserved Domain protein database.
We used PSORT to scan for nuclear and other localization
signal consensus sequences. To identify orthologue forms
of Hinderin in other species, the human protein sequence
was BLASTed against the translated EST database of m. fascicularis, mouse, rat, cow, sheep, dog, zebrafish, c. elegans, drosophila, and s. cereviasie. When a homologous
sequence had been identified in lower organisms, we ran
the COILS program to assess whether it displayed the
same secondary structure as that of the matching human
sequence.
Protein complex immunoprecipitation
293 cells were grown at ~80% confluence in 35 mm cm
plates and transfected with 1 µg of Hinderin-V5 expression vector. After 48 h of incubation, the cells were
washed in ice-cold phosphate-buffered saline and lysed in
1.2 ml of 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1%
Nonidet P40, 0.5% Na-deoxycholate buffer containing
100 mM NaF, 2 mM Na3VO4, and a cocktail of protease
inhibitors. The cell lysate was centrifuged at 12,000 g and
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the recovered supernatant preabsorbed on protein G-agarose. Aliquots (500 µl) of the cell lysate were then incubated overnight at 4°C with either 25 µg of goat antihuman SMC3 antibody or goat anti-human SMC1 antibody (Santa Cruz Biotech) or alternatively with 10 µg
mouse anti-V5 antibody (Invitrogen). The immunocomplexes were captured on Protein G-agarose by incubating
1 h at 4°C. After washing in immunoprecipitation buffer
containing 300 mM NaCl, the protein immunocomplex
was analyzed by SDS-PAGE and the proteins transferred
to nitrocellulose membranes by electroblotting. After saturation in 4% dry milk/0.1% Tween 20 in PBS, the filter
was incubated 1 h at RT with primary antibody. The antiSMC1 and anti-SMC3 immunoprecipitate filter blots were
incubated with anti-V5 monoclonal antibody (200 ng/
ml) whereas the V5 immunoblots were incubated with
either anti SMC1 (100 ng/ml) or anti-SMC3 (100 ng/ml)
antibodies. After incubation with species-specific anti IgG
HRP-conjugated secondary antibody (1:10,000), the
immunocomplexes were visualized by enhanced chemiluminescence reaction (ECL).
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